Galena Biopharma, Inc. (SLS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

And NASA is already buying into this future. Since letting the SLS and Orion contracts, it has almost exclusively awarded "fixed-price" contracts for other elements of its exploration programs.

According to the report, NASA will end up spending a total of $93 billion on the Artemis program between 2012 and 2025, and each SLS/Orion launch will have a price tag of about $4.1 billion.

You mentioned the SLS here and in your book as something ... launched by 2017 and for less than half the price it is now, would have been different. Again, I wasn't very confident that would ...

The average one-year price target for SELLAS Life Sciences Group (NASDAQ:SLS) has been revised to 7.14 / share. This is an increase of 16.67% from the prior estimate of 6.12 dated October 31 ...